Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00073307. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Randomized Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate safety, efficacy (including quality of life), and pharmacokinetics of BAY43-9006 when added to Best Supportive Care in patients with unresectable and/or metastatic renal cell cancer, who have received one prior systemic regimen for advanced disease.
Study identification
- NCT ID
- NCT00073307
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 903 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2003 (Type not available)
- Primary completion
- Sep 2006 (Actual)
- Completion
- Apr 2010 (Actual)
- Last update posted
- Feb 6, 2014
2003 – 2010
United States locations
- U.S. sites
- 31
- U.S. states
- 22
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Tucson | Arizona | 85712 | — |
| Not listed | Los Angeles | California | 90033 | — |
| Not listed | Los Angeles | California | 90057 | — |
| Not listed | Sacramento | California | 95817 | — |
| Not listed | Aurora | Colorado | 80045 | — |
| Not listed | Hamden | Connecticut | 06518 | — |
| Not listed | Atlanta | Georgia | 30309 | — |
| Not listed | Chicago | Illinois | 60637 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | Lafayette | Louisiana | 70506 | — |
| Not listed | Frederick | Maryland | 21701 | — |
| Not listed | Boston | Massachusetts | 02215 | — |
| Not listed | Minneapolis | Minnesota | 55455 | — |
| Not listed | Columbia | Missouri | 65203-3244 | — |
| Not listed | St Louis | Missouri | 63110-1093 | — |
| Not listed | Brooklyn | New York | 11220 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | The Bronx | New York | 10466-2604 | — |
| Not listed | Canton | Ohio | 44718 | — |
| Not listed | Cleveland | Ohio | 44195 | — |
| Not listed | Dayton | Ohio | 45429 | — |
| Not listed | Portland | Oregon | 97239 | — |
| Not listed | Philadelphia | Pennsylvania | 19107-5096 | — |
| Not listed | Spartanburg | South Carolina | 29303 | — |
| Not listed | Dallas | Texas | 75246 | — |
| Not listed | Laredo | Texas | 78041 | — |
| Not listed | San Antonio | Texas | 78212 | — |
| Not listed | Salt Lake City | Utah | 84132 | — |
| Not listed | Richmond | Virginia | 23229 | — |
| Not listed | Seattle | Washington | 98101 | — |
| Not listed | Milwaukee | Wisconsin | 53226-3596 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 90 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00073307, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 6, 2014 · Synced Nov 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.